References
- Beck ML, Tilzer LL. Red cell compatibility testing: a perspective for the future. Transfus Med Rev 1996; X:118-30.
- Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
- Shulman IA, Nelson JM, Okamoto M, et al. The dependence of anti-Jka detection on screening cell zygosity. Lab Med 1985;16:602-4.
- Shulman IA, Yaowasiriwatt M, Saxena S, et al. Influence of reagent RBC zygosity on anti-Fya detection.Lab Med 1989;20:37-9.
- Grove-Rasmussen M. Routine compatiblity testing. Transfusion 1964;4:200-5.
- Giblett ER. Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 1977;17:299-308.
- Mintz PD, Nordine RB, Henry JB, et al. Expected hemotherapy in elective surgery. NY State J Med 1976;76:532-7.
- Friedman BA,Oberman HA, Chadwick AR,et al. The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;16:380-7.
- Boral LI,Henry JB.The type and screen: a safe alternative and supplement in selected surgical procedures.Transfusion 1977;17:163-8.
- Boral LI, Hill SS, Apollon CJ,et al.The type and antibody screen, revisited. Am J Clin Pathol 1979; 71:578-81.
- Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion.Transfusion 1978;18:137-41.
- Garratty G. The role of compatibility tests. Transfusion 1982;22:169-72.
- Oberman HA. Abbreviation or elimination of the crossmatch. Clin Lab Med 1982;2:181-92.
- Lown JAG,Barr AL, Jackson JM.A reappraisal of pretransfusion testing procedures in a hospital blood bank. Pathology 1985;17:489-92.
- Mintz D, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test.Transfusion 1982;22:107-10.
- Shulman IA, Nelson JM, Saxena S,et al. Experience with the routine use of an abbreviated crossmatch. Am J Clin Pathol 1984;82:178-81.
- Judd WJ. Commentary: testing for unexpected red cell antibodies—two or three reagent red cell samples? Immunohematology 1997;13:90-3.
- Shulman IA. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch. Arch Pathol Lab Med 1990; 114:412-4.
- Walker RH. On the safety of the abbreviated cross-match.In:Polesky HF,Walker RH,eds.Safety in transfusion practices. Skokie, IL: College of American Pathologists,1982:71-105.
- Wallis JP, Hedley GP, Charlton D, et al. The incidence of anti-Wra and Wra antigen in blood donors and hospital patients. Transfus Med 1996;6:361-4.
- Arriaga F, Alvarez C, Llopis F, et al. Incidence and clinical significance of Wright antigen and antibody. In: Book of Abstracts of the ISBT VII European Congress,Paris,2001:169s.
- Rouger P. International Forum. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel? Vox Sang 1982;43:151-68.
- de la Rubia J, Sempere A,Arriaga F,et al.Safety of the antibody screening test as the sole method of pretransfusion testing.Vox Sang 1992;63:141.
- Lubenko A, Contreras M.The incidence of hemolytic disease of the newborn attributable to anti-Wra. Transfusion 1992;32:87-8.
- Lin CK, Mak KH, Cheng G,et al. Serologic characteristics and clinical significance of Miltenberger antibodies among Chinese patients in Hong Kong. Vox Sang 1998;74:559-60.
- Feng CS. The clinical significance of anti-“Mia”. Transfusion 1994;34:1013.
- Garratty G. Factors affecting the pathogenicity of red cell auto- and alloantibodies. In: Nance SJ, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989: 109-69.
- Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis.Transfusion 1995;35:26-32.
- Pineda AA,Vamvakas EC, Gorden LD,et al.Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999; 39:1097-1103.
- Ness PM, Shirey RS, Thoman SK,et al. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688-93.
- Heddle NM, O’Hoski P, Singer J,et al. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579-84.
- Maffei LM, Johnson ST, Shulman IA,et al. Survey on pretransfusion testing. Transfusion 1998;38:343-9.
- Garratty G, Arndt P, Postoway N, et al. Severe hemolytic transfusion reactions associated with antibodies not detectable by routine methods. Transfusion 1996;36:23S.